Lori A. Ehrlich, Ph.D.
Affiliations: | 2005 | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Molecular Biology, Cell BiologyGoogle:
"Lori Ehrlich"Parents
Sign in to add mentor| G David Roodman | grad student | 2005 | University of Pittsburgh | |
| (IL-3-mediated osteoblast inhibition in multiple myeloma.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lentzsch S, Ehrlich LA, Roodman GD. (2007) Pathophysiology of multiple myeloma bone disease. Hematology/Oncology Clinics of North America. 21: 1035-49, viii |
| Francis LK, Alsayed Y, Leleu X, et al. (2006) Combination mammalian target of rapamycin inhibitor rapamycin and HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin has synergistic activity in multiple myeloma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6826-35 |
| Garcia-Palacios V, Chung HY, Choi SJ, et al. (2006) Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing ICAM-1 expression. Annals of the New York Academy of Sciences. 1068: 240-3 |
| Huston A, Lu G, Anderson J, et al. (2006) Herpes-Simplex Thymidine Kinase Gene as a Selective Marker in Evaluating the Bone Marrow Microenvironment in Multiple Myeloma (MM). Blood. 108: 510-510 |
| Ehrlich LA, Roodman GD. (2005) The role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma. Immunological Reviews. 208: 252-66 |
| Ehrlich LA, Chung HY, Ghobrial I, et al. (2005) IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma. Blood. 106: 1407-14 |
| Oba Y, Lee JW, Ehrlich LA, et al. (2005) MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells. Experimental Hematology. 33: 272-8 |
| Lee JW, Chung HY, Ehrlich LA, et al. (2004) IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells. Blood. 103: 2308-15 |
| Ehrlich LA, Ito M, Choi SJ, et al. (2004) IL-3 Inhibits Osteoblast Formation in Multiple Myeloma Via CD45+ Cells. Blood. 104: 2347-2347 |